SCHEMBL8223794

SCHEMBL8223794

CCOC(=O)[C@@]12C[C@H]1/C=C\CCCCC[C@H](N)C(=O)N1C[C@H](O)C[C@H]1C(=O)N2

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ADRB3 P13945 1/20 0.34
▸ ADRA2B P18089 1/20 0.34
▸ ADRA2C P18825 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8212674 1.00 ADRB3 (0.34) ADRB3ADRA2BADRA2C
SCHEMBL11975703 0.91 ADRB3 (0.34) ADRB3ADRA2BADRA2C
SCHEMBL12730861 0.91 ADRB3 (0.34) ADRB3ADRA2BADRA2C
SCHEMBL8379129 0.88 ADRB3 (0.36) ADRB3ADRA2BADRA2C
SCHEMBL8171994 0.88 — —
SCHEMBL13811481 0.88 ADRB3 (0.39) ADRB3ADRA2BADRA2C
SCHEMBL8249373 0.87 DPP4 (0.37) —
SCHEMBL16512401 0.87 ADRB3 (0.38) ADRB3ADRA2BADRA2C
SCHEMBL8243020 0.87 ADRB3 (0.32) ADRB3ADRA2BADRA2C
SCHEMBL8185437 0.86 ADRB3 (0.31) ADRB3ADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2305695-A2 Macrocyclic inhibitors of Hepatitis C virus replication Intermune, Inc. (US) 2011-04-06 — — EP disclosed
EP-2305696-A2 Macrocyclic inhibitors of Hepatitis C virus replication Intermune, Inc. (US) 2011-04-06 — — EP disclosed
WO-2008022006-A2 ARYLALKOXYL HEPATITIS C VIRUS PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2008-02-21 — — WO disclosed
Send feedback